Expansion momentum Millstone Medical is actively expanding facilities and capabilities, including a new 5M testing facility in Bloomfield and upgraded laboratories, signaling growth and increased capacity for post-manufacturing testing and environmental validation services that can accommodate larger client needs.

Testing services growth The launch and expansion of Millstone Testing Services since late 2022, including acquisitions like Ethide Labs, indicate a strong push into comprehensive product, packaging, and environmental testing—a compelling cross-sell for medical device manufacturers seeking end-to-end post-manufacturing support.

End-to-end logistics Core offerings such as clean room packaging, warehousing, finished goods distribution, loaner kit management and reverse logistics present sales angles to manufacturers needing integrated post-manufacturing workflows with reliable supply chain continuity.

Quality focus A stated priority on quality, compliance, and rapid responsiveness positions Millstone as a trusted partner for medical device makers facing stringent regulatory expectations and outsourcing risk—opportunity to upsell premium quality and compliance services.

Mid-market scale Revenue in the 50–100M range with 201–500 employees places Millstone in a sweet spot for mid-market medical device firms seeking scalable, specialized post-manufacturing partners, presenting opportunities to win contracts from peers in the same tier.